News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McLoughlin Margaret
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Bought 8,000 shares
@ $1.23, valued at
$9.8k
|
|
| 05/26/2023 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Granted 27,000 options to buy
@ $1.58, valued at
$42.7k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2020 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 11,029 options to buy
@ $41.73, valued at
$460.2k
|
|
| 03/12/2020 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Bought 550 shares
@ $17, valued at
$9.4k
|
|
| 05/09/2019 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 91,911 options to buy
@ $17, valued at
$1.6M
|
|
| 05/08/2019 |
3
| McLoughlin Margaret (Director) has filed a Form 3 on Cortexyme, Inc. |
|
|